<?xml version="1.0" encoding="UTF-8"?>
<ref id="b36-rmmj-11-3-e0023">
 <label>36</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Elfiky</surname>
    <given-names>AA</given-names>
   </name>
  </person-group>
  <article-title>Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study</article-title>
  <source>Life Sci</source>
  <year>2020</year>
  <volume>253</volume>
  <fpage>117592</fpage>
  <pub-id pub-id-type="doi">10.1016/j.lfs.2020.117592</pub-id>
  <pub-id pub-id-type="pmid">32222463</pub-id>
 </element-citation>
</ref>
